↓ Skip to main content

When Should Iatrogenic Polypharmacy Be Considered a Disease?

Overview of attention for article published in AMA Journal of Ethics, December 2018
Altmetric Badge

Mentioned by

twitter
67 tweeters

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
When Should Iatrogenic Polypharmacy Be Considered a Disease?
Published in
AMA Journal of Ethics, December 2018
DOI 10.1001/amajethics.2018.1133
Pubmed ID

Twitter Demographics

The data shown below were collected from the profiles of 67 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 20%
Student > Ph. D. Student 1 10%
Student > Master 1 10%
Researcher 1 10%
Professor > Associate Professor 1 10%
Other 0 0%
Unknown 4 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 20%
Pharmacology, Toxicology and Pharmaceutical Science 1 10%
Agricultural and Biological Sciences 1 10%
Medicine and Dentistry 1 10%
Neuroscience 1 10%
Other 0 0%
Unknown 4 40%